Servier Pharmaceuticals

ASPARLAS

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Servier Pharmaceuticals

Asparlas HCPCS:

J9118

HCPCS Code Descriptor:

Injection, calaspargase pegol-mknl, 10 units

Category:

J Code

Asparlas NDCs:

72694-0515-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Asparlas CPT Codes:

Potential CPT administration codes for Asparlas can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Asparlas:

ASPARLAS is an Oncology drug manufactured by Servier Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9118 is aligned to the drug ASPARLAS.

ACCESS PRICING AND MORE BY REGISTERING

J9118 Added Date:

October 1, 2019

J9118 Effective Date:

October 1, 2019

J9118 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Asparlas billing and coding information.
Asparlas patient assistance information can be found through ServierOne at the URL: https://www.servierone.com/s/patient
ASPARLAS prescribing information can be found at the link below:
Information regarding ASPARLAS’s side effects can be found at MedlinePlus